6th Jun 2006 07:01
Cyprotex PLC06 June 2006 Press release 6 June 2006 Cyprotex PLC Director's Dealings Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that Mr Robert Morrisson Atwater, a director of theCompany, bought on Friday 2 June 2006 105,000 ordinary shares of 0.1p each inthe capital of the Company at a price of 7.25p per share. As a consequence of this purchase, Mr Atwater's interest in the share capital ofthe Company has increased to 940,000 ordinary shares representing 0.68% of theissued share capital. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater Tel: 016 2550 [email protected] www.cyprotex.comCode Securities LimitedRichard Potts Tel: 020 7776 [email protected] www.codesecurities.com Media enquiries:AbchurchHeather Salmond / Georgina Bonham Tel: 020 7398 7700 [email protected] www.abchurch-group.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L